Amla, commonly called Indian gooseberry, has been used across Ayurvedic medicine for thousands of years, considered a premier "Rasayana" — a category of substances believed to promote longevity and overall vitality — and remains one of the most extensively used ingredients in traditional Ayurvedic formulations today, including the well-known compound preparation triphala.
Amla's exceptionally high vitamin C and polyphenol content has driven a genuinely substantial and growing body of modern clinical research, particularly for cardiovascular and metabolic markers.
Amla has real, consistent evidence for cholesterol and metabolic markers, confirmed across multiple independent randomized controlled trials and a formal meta-analysis. A systematic review and meta-analysis found amla supplementation significantly decreased C-reactive protein, fasting blood glucose, LDL cholesterol, and total cholesterol, while significantly increasing beneficial HDL cholesterol. A placebo-controlled study of 98 dyslipidemic patients found significant reductions in total cholesterol, triglycerides, and LDL over 12 weeks, and a separate 126-participant trial in newly diagnosed type 2 diabetics found a standardized amla extract reduced fasting blood sugar by 21.8% — outperforming the comparison group taking metformin.
The honest context: most of the strongest trials use specific standardized, patented extracts rather than whole amla fruit, and researchers note that amla's safety alongside diabetes medications "has not been adequately studied," raising a real hypoglycemia risk worth knowing. Given a genuine, replicated meta-analysis-level evidence base across multiple independent trials, "Moderate" is the accurate rating — one of the better-evidenced fruits in this Atlas.
Fruit eaten fresh, dried, or made into juice, pickle, or powder; a core ingredient in the Ayurvedic compound formula triphala.